M08.99
Juvenile arthritis, unspecified, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is a term covering various types of arthritis that affect children and teenagers. The specific ICD-10 code M08.99 refers to juvenile arthritis with unspecified manifestations across multiple sites in the body. This condition causes inflammation in the joints and other tissues, which can lead to pain, swelling, and potential long-term joint damage if not properly managed. Juvenile arthritis can impact daily activities, growth, and development, making early diagnosis and treatment important to improve quality of life.
Causes & Symptoms
Clinical Causes: Genetic factors may predispose children to developing juvenile arthritis. An abnormal immune response where the body's immune system attacks healthy joint tissues. Environmental triggers such as infections may play a role, though the exact cause remains unclear. Certain viral or bacterial infections have been studied as potential contributors to autoimmune reactions that lead to juvenile arthritis.
Key Symptoms: Joint pain and swelling, especially in larger joints like knees, ankles, and wrists. Stiffness, particularly in the mornings or after periods of rest. Reduced range of motion in affected joints. Warmth and redness around affected joints. Fever and rash in some cases. Fatigue and irritability. Possible growth disturbances or joint deformities over time if untreated.
Diagnostic & Treatment
Diagnosis Path: Diagnosing juvenile arthritis involves a comprehensive clinical evaluation that includes medical history and physical examination. Since symptoms can mimic other conditions, doctors may use various tests such as blood tests to look for inflammation markers, rheumatoid factor, or antinuclear antibodies. Imaging techniques like X-rays, ultrasound, or MRI may be employed to assess joint damage or inflammation. The diagnosis is often made after ruling out other possible causes of joint symptoms and may involve a multidisciplinary team of healthcare providers.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and swelling. Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate to slow disease progression. Biologic agents that target specific parts of the immune system. Physical therapy to maintain joint flexibility and muscle strength. Occupational therapy for assistance with daily activities. Regular monitoring and follow-up to assess disease activity and adjust treatments.
Clinical Advice & FAQs
Billing Guidance
Is M08.99 a billable ICD-10 code?
Yes, M08.99 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.99?
Clinical documentation must specify the nature of Juvenile arthritis, unspecified, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
